Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cutting Edge: Epstein-Barr Virus Transactivates the HERV-K18 Superantigen by Docking to the Human Complement Receptor 2 (CD21) on Primary B Cells

1 Aug 2006

Abstract excerpt

EBV, a ubiquitous human herpesvirus, is the causative agent of infectious mononucleosis and is associated with many carcinomas. We have previously shown that the EBV latent genes LMP-1 and LMP-2A (for latent membrane proteins 1 and 2A), transactivate a human endogenous retrovirus (HERV), HERV-K18, in infected B lymphocytes. The envelope (Env) protein of HERV-K18 encodes a superantigen that strongly stimulates a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histiocytic Disorders and Treatments
Share to Parvovirus B19 Infection Studies
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16887963
DOI: 10.4049/jimmunol.177.4.2056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cutting Edge: Epstein-Barr Virus Transactivates the HERV-K18 Superantigen by Docking to the Human Complement Receptor 2 (CD21) on Primary B CellsPMID 16887963Read ↗

Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 SuperantigenSemantic proximity Read ↗

EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM.Semantic proximity Read ↗

Epstein-Barr Virus Binding to CD21 Activates the Initial Viral Promoter via NF-κB InductionSemantic proximity Read ↗

Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen.Semantic proximity Read ↗

Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigenSemantic proximity Read ↗

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.Semantic proximity Read ↗

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, and enhances the viral infection of Burkitt lymphoma cellsSemantic proximity Read ↗

Human cytomegalovirus regulates surface expression of the viral protein UL18 by means of two motifs present in the cytoplasmic tail.Semantic proximity Read ↗

B cell activation leads to shedding of complement receptor type II (CR2/CD21)Semantic proximity Read ↗

Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a CoreceptorSemantic proximity Read ↗

Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.Semantic proximity Read ↗

The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d bindingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.